Phase I clinical trial evaluating the safety and anti-tumor activity of ADP-A2M10 SPEAR T-cells in patients with MAGE-A10+ head and neck, melanoma, or urothelial tumors
收藏NIAID Data Ecosystem2026-03-13 收录
下载链接：
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE195530
下载链接
链接失效反馈官方服务：
资源简介：
Expression of several gene groups was compared between pre-treatment tumour samples from patients with either head&neck, melanoma or urothelial cancers Pre-treatment (screening or baseline) biopsies from primary or metastatic tumours (3 each: head&neck, melanoma and urothelial cancers) were compared.
创建时间：
2022-04-07
